Enema transplant of fecal microbiota, Double encapsulated oral transplant of fecal microbiota
APHP180572
Phase 2 small_molecule active
Quick answer
Enema transplant of fecal microbiota, Double encapsulated oral transplant of fecal microbiota for Ulcerative Colitis is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Ulcerative Colitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active